scispace - formally typeset
Search or ask a question

Showing papers by "Tippawan Liabsuetrakul published in 2023"


Journal ArticleDOI
TL;DR: In this paper , the authors performed a cost-utility analysis of separated continuous renal replacement therapy (CRRT) compared with intermittent haemodialysis (IHD) in critically ill patients with acute kidney injury (AKI).
Abstract: BACKGROUND The aim of this study is to perform a cost-utility analysis of separated continuous renal replacement therapy (CRRT) compared with intermittent haemodialysis (IHD) in critically ill patients with acute kidney injury (AKI). METHODS Cost and clinical data were gathered from adult patients with AKI who received separated CRRT or IHD at a tertiary hospital in Thailand. We applied a Markov model in this study. Our primary outcome was the incremental cost-effectiveness ratio (ICER). We performed sensitivity analysis to assess the influence of parameter uncertainty. RESULTS We enrolled 199 critically ill patients with AKI. Of these patients, 129 underwent separated CRRT, and the rest underwent IHD. The mortality rate and dialysis dependence status were not significantly different between the groups. The total costs of separated CRRT were lower than IHD ($73,042.20 vs $89,244.37). We estimated that separated CRRT increased quality-adjusted life years (QALYs) by 0.21 compared with IHD. The ICER of -74,035.16 USD/QALY gained in the case-based analysis indicated that separated CRRT is superior to IHD due to the lower cost and more cumulative QALYs. After performing sensitivity analysis by varying parameter ranges, separated CRRT remained a cost-saving approach. CONCLUSIONS Separated CRRT is a cost-saving modality compared with IHD in critically ill patients with AKI. This approach can be applied in resource-limited settings.

Journal ArticleDOI
TL;DR: In this article , the authors assessed the correlations of body composition markers, specifically skeletal muscle mass and fat mass, and their prognostic determinants to the survival of non-metastatic lung cancer patients.
Abstract: Rationale: Lung cancer remains the leading cause of cancer death worldwide. Although previous studies showed lower risk of death in non-small cell lung cancer (NSCLC) patients with greater body mass index (BMI), there were few studies on the effects of body composition, either fat or muscle mass on its survival. This study thus aimed to assess the correlations of body composition markers, specifically skeletal muscle mass and fat mass, and their prognostic determinants to the survival of non-metastatic NSCLC patients.

Journal ArticleDOI
TL;DR: In this article , the most commonly used medications (antiplatelet agents, anticoagulants, antioxidants, nitric oxide, and calcium) for preventing hypertensive disorders of pregnancy (HDP) in high risk pregnant women were searched from the Cochrane Pregnancy and Childbirth's Specialized Register of Controlled Trials until July 31, 2020, without language restriction.